Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated

Cryptogenic stroke patients with migraine have high prevalence (79%) of patent foramen ovale (PFO) with right to left shunt. However, the timing of stroke in migraineurs is not usually associated to a migraine attack. These observations are consistent with the hypothesis that the most likely mechanism of stroke in these patients with migraine is a paradoxical embolus.

Stroke criptogénico y el fin de la controversia sobre el cierre del foramen ovalWe know that individuals with migraine have a higher risk of stroke than the general population, but the problem is we do not have a clear physiopathology of this increased risk yet.

 

Given the frequent association between intra-cardiac shunt and migraine, paradoxical embolus has been proposed as a hypothesis to explain stroke in patients with PFO or intra-pulmonary arteriovenous malformations. The aim of this study was to determine the prevalence of PFO with right to left shunt in patients with cryptogenic stroke and a history of migraine.


Read also: We Should Consider Mitral Stenosis Before TAVR.


All patients presenting with ischemic stroke were characterized based on the ASCOD (atherosclerosis, small vessels disease, heart disease, others, dissection). Migraine diagnosis was done retrospectively, and aura was frequent (50% of the attacks). PFO diagnosis with right to left shunt was determined by a positive a bubble contrast study, either with transcranial doppler, transthoracic or transesophageal echocardiography.

 

Of 712 patients with ischemic stroke included in this study, 18% (127) were diagnosed as cryptogenic stroke and, of these patients, more than half (68 patients) had PFO and a history of migraine.

 

There was a high rate of PFO (79%) in patients with migraine and cryptogenic stroke and an even higher rate (93%) when migraine had an aura.


Read also: Morbidity and Mortality During Authorization Wait-Times for TAVR.


Only 5 patients (4%) had a history compatible with migraine infarction.

 

Conclusion

In patients with cryptogenic shock with migraine, there is high prevalence of patent foramen ovale with right to left shunt. The timing of stroke is normally not associated with a migraine attack, which is why these patients’ most likely physiopathological mechanism is a paradoxical embolus, as in those not presenting migraine. Future classification of cryptogenic stroke should consider patent foramen ovale as a separate etiological category.

 

Original title: Frequency of Patent Foramen Ovale and Migraine in Patients with Cryptogenic Stroke.

Reference: Brian H. West et al. Stroke. 2018;49:00-00.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...